# 17,000 Apps Reveal Optimal Free Trial Lengths for Conversion Annual plans convert 86% better with 30-day trials while AI apps hit diminishing returns after 16 days - **Source:** [SaaStr](https://www.saastr.com) - **Published:** 2026-09-29 - **Topic:** [Marketing](https://brifing.si/c/marketing) - **Original article:** - **On Brifing:** https://brifing.si/s/766a53f8-c4f9-4475-8e1e-f6a213c2c07c ## Annual plans demand longer trials RevenueCat's study of 17,000+ mobile apps shows annual subscriptions convert 44.6% with 17-32 day trials versus just 24% for trials under 4 days. First renewal rates nearly triple from 18.3% to 47.5% with longer trials. The combined metric of users who both convert and renew jumps from 3.5% to 18.5% - a 5x difference in retained customers from the same number of trial starts. ## Monthly plans peak at 2 weeks For monthly subscriptions, conversion peaks at 46.6% for 10-16 day trials before declining. First renewal continues climbing to 77.5% at 17-32 days. The sweet spot depends on whether conversion or retention is the bigger challenge - standard 14-day trials land in the optimal range. No-trial monthly buyers renew at just 49.5% versus 72-77.5% after extended trials. ## AI apps face unique constraints AI products show diminishing returns past 16-day trials, with monthly conversion dropping from 38.5% to 31.8%. Unlike traditional software, each free session burns costly inference. Annual AI plans follow similar patterns but at lower rates - 33.8% conversion for 10-16 day trials versus 23.3% at 5-9 days. The margin for error is thinner with AI's variable costs. ## Utilities mirror B2B patterns Utility apps - closest to B2B productivity tools - show conversion peaking at 10-16 days (47.4%) while renewal climbs steadily to 77.9% for longest trials. Short trials prove functionality while extended trials enable workflow integration and multi-seat adoption - critical for B2B renewal rates that mirror these patterns. ## Regional conversion differences North America and Western Europe show consistent conversion gains with longer annual trials. Asia-Pacific follows suit until 16+ days where conversion drops. Monthly plans reveal stark regional differences - Middle East/Africa converts best at 5-9 days (38.3%) but worst at 17-32 days (27.4%). Global expansion requires localized trial strategies. ## The hidden cost of short annual trials Short trials paired with annual pushes perform worst in the dataset - just 18.3% renewal versus 26.6% for no-trial annual buyers. These likely represent poorly qualified leads pressured into long commitments. The data suggests separating trial length decisions from pricing plan promotions for cleaner measurement. ## Behavioral vs. time-based metrics RevenueCat notes users active on day 25 of any trial length convert better - part of longer trials' success comes from self-selection. This correlation suggests engagement metrics may complement pure time-based approaches, especially for products with clear usage signals like B2B tools with seat expansion patterns. ## Testing beats industry defaults The study reveals most top apps copy category leaders' trial lengths without testing - 81-100 of each category's top 100 apps use trials under 4 days for weekly plans. Yet performance data often favors longer options. B2B similarly adopted 14-day trials from early SaaS leaders without evidence it matches their time-to-value. ## Strategic trial length decisions Key takeaways: 1) Annual plans need 30-day trials, 2) Monthly plans optimize at 10-16 days, 3) AI apps should cap at 2 weeks with usage limits, 4) Never pair short trials with annual pushes, 5) Regional differences require testing. Most B2B teams set trial lengths years ago - this data suggests systematic reevaluation could recover lost conversions. ## Sources covering this story - https://www.saastr.com/what-17000-subscription-apps-tell-us-about-free-trial-length-annual-plans-convert-86-better-with-30-day-trials-monthly-tops-out-at-two-weeks-and-ai-apps-hit-a-wall-at-16-days/ — --- _Summary written by Brifing from the original reporting. Copyright in the original article belongs to its publisher; read the full piece at the link above._